Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma. | Int J Mol Sci | 2022 | 36430324 | PubTator, text mining | PubMed |
| The Molecular Signature of Human Testicular Peritubular Cells Revealed by Single-Cell Analysis. | Cells | 2022 | 36429113 | PubTator, text mining | PubMed |
| Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia. | Cancers (Basel) | 2022 | 36428690 | PubTator, text mining | PubMed |
| Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428603 | PubTator, text mining | PubMed |
| Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis. | Acta Histochem Cytochem | 2022 | 36405550 | PubTator, text mining | PubMed |
| The conversion of β-carotene to vitamin A in adipocytes drives the anti-obesogenic effects of β-carotene in mice. | Mol Metab | 2022 | 36400405 | PubTator, text mining | PubMed |
| ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. | Front Oncol | 2022 | 36387165 | PubTator, text mining | PubMed |
| Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression. | Int J Mol Sci | 2022 | 36362068 | PubTator, text mining | PubMed |
| Generation of Lens Progenitor Cells and Lentoid Bodies from Pluripotent Stem Cells: Novel Tools for Human Lens Development and Ocular Disease Etiology. | Cells | 2022 | 36359912 | PubTator, text mining | PubMed |
| SOD3 Expression in Tumor Stroma Provides the Tumor Vessel Maturity in Oral Squamous Cell Carcinoma. | Biomedicines | 2022 | 36359248 | PubTator, text mining | PubMed |
| Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. | Cancers (Basel) | 2022 | 36358843 | PubTator, text mining | PubMed |
| A review on the role of mir-16-5p in the carcinogenesis. | Cancer Cell Int | 2022 | 36348403 | PubTator, text mining | PubMed |
| Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. | Front Immunol | 2022 | 36341373 | PubTator, text mining | PubMed |
| A Case of Bilateral Microphthalmia and Extensive Colobomas of the Globes Associated with a Likely Pathogenic Homozygous SIX6 Variant. | Case Rep Ophthalmol | 2022 | 36341038 | PubTator, text mining | PubMed |
| Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. | Front Oncol | 2022 | 36338705 | PubTator, text mining | PubMed |
| miR-3614-5p downregulation promotes cadmium-induced breast cancer cell proliferation and metastasis by targeting TXNRD1. | Ecotoxicol Environ Saf | 2022 | 36335879 | PubTator, text mining | PubMed |
| Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Sci Adv | 2022 | 36322658 | PubTator, text mining | PubMed |
| RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating RAC1 activation. | Breast Cancer Res | 2022 | 36307864 | PubTator, text mining | PubMed |
| Zmiz1 is required for mature β-cell function and mass expansion upon high fat feeding. | Mol Metab | 2022 | 36307047 | PubTator, text mining | PubMed |
| Cell-autonomous lipid-handling defects in Stargardt iPSC-derived retinal pigment epithelium cells. | Stem Cell Reports | 2022 | 36306781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=19